Subject(s)
Carcinoma, Hepatocellular/drug therapy , Liver Neoplasms/drug therapy , Pregnanes/therapeutic use , BCG Vaccine/therapeutic use , Carcinoma, Hepatocellular/mortality , Carcinoma, Hepatocellular/surgery , Clinical Trials as Topic , Drug Evaluation , Ethanolamines/administration & dosage , Ethanolamines/therapeutic use , Hepatic Artery/surgery , Humans , Immunotherapy , Injections, Intramuscular , Ketosteroids/administration & dosage , Ketosteroids/therapeutic use , Ligation , Liver Neoplasms/mortality , Liver Neoplasms/surgery , Pregnanes/administration & dosageABSTRACT
The anabolic activity of formebolone was studied in 7 patients with nephrosis or renal insufficiency by measuring the amount of 14C-leucine incorporated into plasma proteins as an index of protein synthesis. The data demonstrate that the incorporation of label into the plasma albumin fraction was significantly increased after formebolone administration.
Subject(s)
Acute Kidney Injury/metabolism , Anabolic Agents/administration & dosage , Androstenediols/administration & dosage , Nephrosis/metabolism , Protein Biosynthesis , Adult , Aged , Blood Proteins/biosynthesis , Carbon Radioisotopes/metabolism , Female , Formaldehyde/administration & dosage , Formaldehyde/analogs & derivatives , Humans , Ketosteroids/administration & dosage , Leucine/blood , Leucine/metabolism , Male , Middle Aged , Serum Albumin/analysisSubject(s)
Glucocorticoids/administration & dosage , Skin/drug effects , Vasoconstrictor Agents , Acetals/administration & dosage , Acetals/pharmacology , Adolescent , Adult , Atrophy , Female , Humans , Hydrocortisone/administration & dosage , Hydrocortisone/pharmacology , Injections, Intradermal , Ketosteroids/administration & dosage , Ketosteroids/pharmacology , Male , Pregnadienetriols/administration & dosage , Pregnadienetriols/pharmacology , Radiation Effects , Skin/pathology , Skin/radiation effects , Skin Pigmentation/drug effects , Time Factors , Triamcinolone Acetonide/administration & dosage , Triamcinolone Acetonide/pharmacology , Ultraviolet RaysSubject(s)
Fertility/drug effects , Gonanes/pharmacology , Progesterone Congeners/pharmacology , Progesterone/antagonists & inhibitors , Adult , Drug Evaluation , Female , Gonanes/administration & dosage , Gonanes/adverse effects , Humans , Hydroxysteroids/administration & dosage , Hydroxysteroids/adverse effects , Hydroxysteroids/pharmacology , Ketosteroids/administration & dosage , Ketosteroids/adverse effects , Ketosteroids/pharmacology , Menstruation/drug effects , Pregnancy , Receptors, Cell Surface , Vomiting/chemically inducedABSTRACT
PIP: A moderately effective oral progestogen contraceptive, R-2323 (13beta-ethyl-17alpha-ethynyl-17-hydroxy-gona-4,9,11-trien,3-one), was administered weekly in doses of 2.5 mg and 5 mg to 5 subjects each for 8 weeks. In 2 of the 10 treatment cycles of 2.5 mg and 4 of the 10 treatment cycles of 5 mg, progesterone levels indicative of anovulation were obtained. In each of these cycles, an absence of the midcycle luteinizing hormone (LH) peak was noted. In an additional 5 cycles with absence of an LH peak, ovulatory steroid patterns were present. The remaining 9 cycles showed gonadotropin and steroid patterns consistent with ovulation. It is concluded that the main contraceptive mechanism is probably other than inhibition of ovulation. Increased viscosity of the cervical mucus is considered a possible means of contraception.^ieng
Subject(s)
Contraceptives, Oral/administration & dosage , Gonadotropins/metabolism , Gonanes/administration & dosage , Ovulation/drug effects , Pituitary Gland/drug effects , Adult , Binding, Competitive , Contraceptives, Oral/pharmacology , Estradiol/blood , Female , Follicle Stimulating Hormone/blood , Gonanes/pharmacology , Humans , Hydroxysteroids/administration & dosage , Hydroxysteroids/pharmacology , Ketosteroids/administration & dosage , Ketosteroids/pharmacology , Luteinizing Hormone/blood , Ovary/drug effects , Progesterone/blood , Protein Binding , RadioimmunoassaySubject(s)
Gonanes/pharmacology , Progestins/pharmacology , Adolescent , Adult , Amenorrhea/chemically induced , Biopsy , Drug Evaluation , Endometrium/pathology , Estrogens/blood , Female , Fertilization/drug effects , Gonanes/administration & dosage , Gonanes/adverse effects , Humans , Hydroxysteroids/administration & dosage , Hydroxysteroids/adverse effects , Hydroxysteroids/pharmacology , Ketosteroids/administration & dosage , Ketosteroids/adverse effects , Ketosteroids/pharmacology , Menstruation/drug effects , Menstruation Disturbances/chemically induced , Metrorrhagia/chemically induced , Pregnancy , Progestins/adverse effectsSubject(s)
Leg Ulcer/drug therapy , Ointments , Pharmaceutic Aids , Pregnadienetriols/administration & dosage , Steroids, Fluorinated/administration & dosage , Acetates/administration & dosage , Acetates/therapeutic use , Aged , Clinical Trials as Topic , Drug Evaluation , Female , Granulation Tissue/drug effects , Humans , Ketosteroids/administration & dosage , Ketosteroids/therapeutic use , Male , Middle Aged , Pregnadienetriols/therapeutic use , Steroids, Fluorinated/therapeutic use , Wound Healing/drug effectsSubject(s)
Anesthesia, Intravenous , Anesthetics/administration & dosage , Hydroxysteroids/administration & dosage , Liver/drug effects , Alanine Transaminase/blood , Aspartate Aminotransferases/blood , Bilirubin/blood , Diazepam/administration & dosage , Ethanol/administration & dosage , Female , Genital Diseases, Female/surgery , Humans , Ketamine/administration & dosage , Ketosteroids/administration & dosage , L-Lactate Dehydrogenase/blood , Liver/physiology , Liver Function Tests , Metaproterenol/administration & dosage , Minor Surgical Procedures , Propanidid/administration & dosage , Surgical Procedures, Operative , Thiopental/administration & dosageSubject(s)
Adipose Tissue/drug effects , Blood Glucose/metabolism , Insulin/blood , Pregnadienes/pharmacology , Progestins/pharmacology , Animals , Carbon Radioisotopes , Fatty Acids, Nonesterified/blood , Female , Glucose Tolerance Test , Glycogen/metabolism , Injections, Subcutaneous , Ketosteroids/administration & dosage , Ketosteroids/pharmacology , Liver/metabolism , Male , Pregnadienes/administration & dosage , Progestins/administration & dosage , Radioimmunoassay , Rats , Steroids, Chlorinated/administration & dosage , Steroids, Chlorinated/pharmacology , Time FactorsSubject(s)
Contraceptives, Oral/administration & dosage , Fallopian Tubes/drug effects , Fertility/drug effects , Gonads/drug effects , Norpregnanes/administration & dosage , Pregnadienediols/administration & dosage , Pregnenediones/administration & dosage , Progestins/administration & dosage , Adult , Contraceptives, Oral/pharmacology , Corpus Luteum/cytology , Corpus Luteum/drug effects , Dose-Response Relationship, Drug , Endometrium/cytology , Epithelial Cells , Epithelium/drug effects , Fallopian Tubes/cytology , Fallopian Tubes/physiology , Female , Gonads/cytology , Histocytochemistry , Humans , Hydroxysteroids/administration & dosage , Ketosteroids/administration & dosage , Microscopy, Electron , Ovarian Follicle/cytology , Ovarian Follicle/drug effects , Ovary/cytology , Ovulation/drug effects , Oxidoreductases/metabolism , Pregnatrienes/administration & dosage , Pregnenediones/pharmacology , Progestins/pharmacology , Steroids, Chlorinated/administration & dosage , Sulfides/administration & dosageSubject(s)
Contraceptives, Oral/administration & dosage , Progestins/administration & dosage , Adolescent , Adult , Cervix Mucus/drug effects , Clinical Trials as Topic , Coitus , Contraceptives, Oral/pharmacology , Dose-Response Relationship, Drug , Endometrium/drug effects , Ethynodiol Diacetate/administration & dosage , Ethynodiol Diacetate/pharmacology , Female , Follicle Stimulating Hormone/metabolism , Humans , Hydroxysteroids/administration & dosage , Ketosteroids/administration & dosage , Luteinizing Hormone/metabolism , Menstruation/drug effects , Norpregnanes/administration & dosage , Norpregnanes/pharmacology , Ovary/drug effects , Pregnadienediols/administration & dosage , Pregnanediol/urine , Pregnatrienes/administration & dosage , Pregnenediones/administration & dosage , Progestins/adverse effects , Progestins/pharmacology , Steroids, Chlorinated/administration & dosage , Sulfides/administration & dosage , Vagina/cytology , Vagina/drug effectsSubject(s)
Adrenal Cortex Hormones/pharmacology , Pituitary-Adrenal System/drug effects , Prednisolone/pharmacology , 11-Hydroxycorticosteroids/blood , Adrenal Cortex Hormones/administration & dosage , Adult , Fluorometry , Humans , Ketosteroids/administration & dosage , Ketosteroids/pharmacology , Middle Aged , Prednisolone/administration & dosage , Steroids, Fluorinated/administration & dosage , Steroids, Fluorinated/pharmacology , Time FactorsSubject(s)
Betamethasone/pharmacology , Dexamethasone/pharmacology , Pregnadienetriols/pharmacology , Vasoconstrictor Agents/pharmacology , Administration, Topical , Betamethasone/administration & dosage , Betamethasone/metabolism , Dexamethasone/administration & dosage , Dexamethasone/metabolism , Female , Humans , Ketosteroids/administration & dosage , Ketosteroids/metabolism , Ketosteroids/pharmacology , Male , Pharmaceutical Vehicles , Pregnadienetriols/administration & dosage , Pregnadienetriols/metabolism , Skin Absorption , Solubility , Steroids, Fluorinated/administration & dosage , Steroids, Fluorinated/metabolism , Steroids, Fluorinated/pharmacology , Vasoconstrictor Agents/administration & dosage , Vasoconstrictor Agents/metabolismABSTRACT
The erythropoietic effect of 5beta-pregnane-3beta-hydroxy-20-one, a naturally occurring steroid metabolite of progesterone, was evaluated in the squirrel monkey by ferrokinetic studies. red cell survival, and blood volume measurements. The intramuscular administration of this steroid in pharmacologic doses shortened the (59)Fe plasma clearance and increased the plasma iron turnover, thereby indicating an increase in erythropoiesis. A normal (59)Fe red cell uptake was observed, and the bone marrow maturation time was not altered. Red cell survival was the same in the treated and control groups. After five weekly injections of the steroid, the monkeys increased their red cell mass by 57%. A significant increase in white blood cells and a slight elevation of platelet counts in the treated monkeys also suggest a possible direct stimulation of hemopoietic stem cells by the steroid metabolite. These observations indicate that some steroid metabolites can stimulate an early increase in iron turnover (within 48 h) that is not secondary to hemolysis. The increased red cell mass indicates effective erythropoiesis in primates.